CRUK/19/013 VICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: A Molecularly Guided Phase 2 Study

Project: Research

Project Details

StatusActive
Effective start/end date1/02/202031/07/2025

Collaborative partners

Funding

  • CRUK Cancer Research UK: £859,748.06